We are discussing a case of severe drug-induced agranulocytosis following the simultaneous administration of chlorpromazine and TMP/SMX in a patient presenting with sepsis, discussing possible hypotheses that could explain this observation and highlighting the response to treatment with G-CSF in such scenario. The gene discussed is CSF3; the disease is Absence of circulating granulocytes.